Abstract
A total of 7,764 isolates from patients with invasive pneumococcal disease (IPD) were collected from 1992 to June 2006. Data on serotypes were available for 5,022 isolates (64.7% of all invasive isolates). Some 54.0% of the isolates originated from adults >or=16 years of age, and 46.0% were from children <16 years of age. The leading serotypes were 14, 23F, 1, 6B, 7F, 3, and 4. The serotypes significantly more common in children were 14, 6B, 19F, and 18C, while among adults, serotypes 3 and 4 were predominant. Serotype 7F was statistically more prevalent among children <4 months old than among the other age groups. Among children aged >or=4 months and <1 year, serotype 19F occurred statistically more frequently; and among children aged >or=1 year to <5 years, serotypes 14, 6B, and 18C were overrepresented. The serotypes predominantly affecting patients younger than the remaining collective of patients were 14, 6B, 19F, and 18C, while patients with IPD caused by serotypes 3, 4, and 9V were older than the collective, on average.
References
Dec 1, 1987·European Journal of Clinical Microbiology·A KaufholdJ Henrichsen
Mar 1, 1981·Reviews of Infectious Diseases·R Austrian
Jun 1, 1994·Journal of Clinical Microbiology·J F PlouffeR R Facklam
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A ScottA Taunay
Jan 3, 2001·The New England Journal of Medicine·C G WhitneyUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Feb 24, 2001·Acta Paediatrica. Supplement·E MillerR George
Feb 24, 2001·Acta Paediatrica. Supplement· KaltoftH B Konradsen
Apr 13, 2001·JAMA : the Journal of the American Medical Association·K A RobinsonUNKNOWN Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel R Feikin, Keith P Klugman
Nov 5, 2003·Pediatrics·Jill A HoffmanSheldon L Kaplan
Sep 4, 2004·The Journal of Infectious Diseases·Angela B BrueggemannBrian G Spratt
Nov 10, 2004·International Journal of Medical Microbiology : IJMM·Ralf René Reinert
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel R FeikinUNKNOWN Active Bacterial Core surveillance/Emerging Infections Program Network
Jul 26, 2005·Infection and Immunity·Sven HammerschmidtManfred Rohde
Nov 26, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R R ReinertD S Fedson
Jun 23, 2006·The Lancet Infectious Diseases·Tom JeffersonPiero Borgia
Nov 15, 2007·The Journal of Antimicrobial Chemotherapy·Johan FlamaingWilly E Peetermans
Feb 1, 2008·Journal of Clinical Microbiology·Michael R JacobsCynthia G Whitney
Jun 3, 2008·Vaccine·Zitta B HarboeHelle B Konradsen
Jul 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rochelle LacapaKatherine L O'Brien
May 27, 2009·PLoS Medicine·Zitta B HarboeThomas L Benfield
Jun 11, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James D KellnerDavid W Scheifele
Jun 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Angelique G S C JansenEelko Hak
Jul 17, 2009·International Journal of Medical Microbiology : IJMM·Matthias ImöhlMark van der Linden
Aug 18, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M ImöhlM van der Linden
Citations
Nov 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L SelvaC Muñoz-Almagro
Jun 22, 2012·Cardiology in the Young·Lee MorrisMichael Tosi
Nov 27, 2010·BMC Microbiology·Matthias ImöhlMark van der Linden
Apr 18, 2013·PloS One·Mark van der LindenMatthias Imöhl
Jun 15, 2013·Emerging Infectious Diseases·Sandra S RichterGary V Doern
Nov 15, 2011·Expert Opinion on Biological Therapy·Robert W Frenck, Sylvia Yeh
Oct 22, 2013·Diagnostic Microbiology and Infectious Disease·Amity L RobertsPeter C Iwen
Nov 26, 2015·Vaccine·Altynay ShigayevaUNKNOWN Toronto Invasive Bacterial Diseases Network
Sep 16, 2011·Vaccine·Gail L Rodgers, Keith P Klugman
May 18, 2010·Vaccine·Matthias ImöhlRalf René Reinert
May 18, 2010·International Journal of Antimicrobial Agents·Moses L JolobaMichael R Jacobs
Sep 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Altynay ShigayevaUNKNOWN Toronto Invasive Bacterial Diseases Network
May 10, 2013·Journal of Medical Microbiology·Sungkyoung LeeYeonho Kang
Apr 18, 2015·BMC Infectious Diseases·Matthias ImöhlOrhan Aktas
Mar 23, 2011·International Journal of Antimicrobial Agents·Christine BleyRalf René Reinert
Feb 26, 2014·Vaccine·Catherine Weil-Olivier, Jacques Gaillat
Nov 22, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E del AmoC Muñoz-Almagro
Sep 5, 2014·PLoS Pathogens·Kristin R WadeRodney K Tweten
Jun 18, 2016·BioMed Research International·Si Hyun KimJeong Hwan Shin
Aug 18, 2016·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Vicki MountEmma Best
Jul 18, 2017·Zdravstveno Varstvo·Maja Kolšek-ŠušteršičJanez Rifel
Aug 4, 2011·Expert Review of Vaccines·David S FedsonSandrine I Samson
Aug 8, 2017·Expert Review of Vaccines·Raul IsturizLuis Jodar
Jun 13, 2020·Human Vaccines & Immunotherapeutics·Ma-Chao LiYing-Chun Xu
Jul 2, 2016·Pneumonia·Diana C Otczyk, Allan W Cripps
Apr 30, 2017·PloS One·Ana Cristina Paulo, Raquel Sá-Leão
May 19, 2021·Genome Medicine·Stephen D Bentley, Stephanie W Lo
Apr 21, 2020·Infectious Disorders Drug Targets·Abdollah KarimiSedigheh Rafiei Tabatabaei